Fund shareholders of Newamsterdam Pharma Co NV
ISIN NL00150012L7 · Netherlands · LEI 984500B6549TF6E14D36
- Fund shareholders
- 137
- Of which ETFs
- 18 119 other funds
- Value held
- 890.9M $ 293.8M SEK
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC | 7,683 | 245.9K $ | 0.24 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 7,408 | 211.6K $ | 0.57 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 7,200 | 230.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Global Atlantic Wellington Research Managed Risk Portfolio Forethought Variable Insurance Trust | 6,700 | 214.5K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 6,442 | 228.4K $ | 0.30 % | as of Feb 28, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 6,433 | 205.9K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 6,347 | 203.2K $ | 0.14 % | as of Mar 31, 2026 ↗ |
| AST PGIM Aggressive Multi-Asset Portfolio Advanced Series Trust | 5,953 | 190.6K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 5,735 | 183.6K $ | 0.38 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 5,236 | 185.7K $ | 0.20 % | as of Feb 28, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 5,121 | 163.9K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| NORTH SQUARE KENNEDY MICROCAP FUND Exchange Place Advisors Trust | 4,701 | 166.7K $ | 0.56 % | as of Feb 28, 2026 ↗ |
| Column Small Cap Fund Trust for Professional Managers | 4,484 | 159K $ | 0.03 % | as of Feb 28, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 3,750 | 120K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Small-Cap Core Equity Fund Prudential Investment Portfolios 2 | 3,437 | 98.2K $ | 0.79 % | as of Apr 30, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 3,375 | 119.7K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| First Trust Multi Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 3,338 | 95.3K $ | 0.02 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 3,053 | 97.7K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 2,782 | 98.6K $ | 0.35 % | as of Feb 28, 2026 ↗ |
| AVIP AB Mid Cap Core Portfolio AuguStar Variable Insurance Products Fund Inc | 2,713 | 86.8K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 2,383 | 76.3K $ | 3.57 % | as of Mar 31, 2026 ↗ |
| BNY Mellon Mid Cap Multi-Strategy Fund BNY MELLON FUNDS TRUST | 2,195 | 77.8K $ | 0.06 % | as of Feb 28, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 1,944 | 55.5K $ | 0.68 % | as of Apr 30, 2026 ↗ |
| Tax-Aware Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 1,805 | 57.8K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 1,293 | 41.4K $ | 0.19 % | as of Mar 31, 2026 ↗ |
| Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 741 | 23.7K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Science & Technology Fund Victory Portfolios III | 727 | 20.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 702 | 24.9K $ | 0.28 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Stock K6 Fund Fidelity Concord Street Trust | 578 | 16.5K $ | 0.09 % | as of Apr 30, 2026 ↗ |
| Strategic Allocation: Aggressive Fund American Century Strategic Asset Allocations Inc | 555 | 15.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Strategic Allocation: Moderate Fund American Century Strategic Asset Allocations Inc | 458 | 13.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 452 | 12.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Small-Cap Equity V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 371 | 11.9K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 293 | 10.4K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Strategic Allocation: Conservative Fund American Century Strategic Asset Allocations Inc | 125 | 3.6K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 85 | 2.7K $ | 0.55 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 8 | 283.7 $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 3.57 % | as of Mar 31, 2026 ↗ |
| Vistashares Target 15 Drukmacro Distribution ETF Tidal Trust III | 2.95 % | as of Apr 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 2.70 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 2.60 % | as of Feb 28, 2026 ↗ |
| AMG TimesSquare Small Cap Growth Fund AMG Funds | 1.36 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 1.30 % | as of Feb 27, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 1.19 % | as of Mar 31, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 1.09 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.88 % | as of Apr 30, 2026 ↗ |
| Global X Guru Index ETF GLOBAL X FUNDS | 0.87 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 131 | +6 | 28,209,992 | +6.7 % |
| 2026Q1 | 125 | +30 | 26,434,947 | +8.0 % |
| 2025Q4 | 95 | +24 | 24,469,398 | +22.0 % |
| 2025Q3 | 71 | +7 | 20,056,412 | +26.8 % |
| 2025Q2 | 64 | +11 | 15,814,930 | +67.5 % |
| 2025Q1 | 53 | +38 | 9,443,970 | +714.2 % |
| 2024Q4 | 15 | +3 | 1,159,973 | +18.8 % |
| 2024Q3 | 12 | +1 | 976,283 | +11.0 % |
| 2024Q2 | 11 | +10 | 879,537 | +1,758.5 % |
| 2024Q1 | 1 | 0 | 47,324 | +28.1 % |
| 2023Q4 | 1 | 36,932 |
Cite this page
Titelia. "Fund shareholders of Newamsterdam Pharma Co NV". https://titelia.com/en/stocks/newamsterdam-pharma-co-nv-NL00150012L7